Title : The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.

Pub. Date : 2021 Sep 7

PMID : 34571986






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Platelet-Activating Factor Receptor"s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine. rupatadine platelet activating factor receptor Homo sapiens
2 The clinically approved PAFR antagonist rupatadine effectively inhibited in vitro cell proliferation and migration of ovarian cancer cells. rupatadine platelet activating factor receptor Homo sapiens
3 PAFR is a prognostic marker in ovarian cancer patients and its inhibition through rupatadine may have important therapeutic implications in the therapy of ovarian cancer patients. rupatadine platelet activating factor receptor Homo sapiens